ReviewTranslational oncology2022

Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer.

Remziye Zaim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.